News
September 14, 2022
Tibsovo®
Onco360 has been added as a trusted specialty pharmacy provider for Tibsovo® (ivosidenib) tablets
June 6, 2022
ORGOVYX®
ORGOVYX® (relugolix) Now Available from Onco360 for the Treatment of Adult Patients with Advanced Prostate Cancer
March 3, 2022
VONJOTM (pacritinib) Available from Onco360
Onco360 has been chosen as a trusted specialty pharmacy to dispense VONJO™ - the first FDA approved therapy that specifically addresses the needs of Adult Cytopenic Myelofibrosis.
November 18, 2021
BESREMi® Available From Onco360
BESREMi® (ropeginterferon alfa-2b-njft) Now Approved for the Treatment of Adults with Polycythemia Vera
September 17, 2021
EXKIVITYTM Available From Onco360
EXKIVITY (mobocertinib) approved and Takeda has selected Onco360® as a Specialty Pharmacy Partner
August 18, 2021
WELIREG™ Available From Onco360
Onco360® has been selected by Merck & Co., Inc. to be in the specialty pharmacy network for WELIREG (belzutifan) ), a hypoxia-inducible factor inhibitor indicated for the treatment of adult patients with von Hippel-Lindau (VHL) disease who require therapy for associated renal cell carcinoma (RCC), central nervous system (CNS) hemangioblastomas, or pancreatic neuroendocrine tumors (pNET), not requiring immediate surgery.
July 22, 2021
REZUROCKTM Available From Onco360
REZUROCKTM (belumosudil) tablets approved to treat adult and pediatric patients 12 years and older with chronic graft-versus-host disease after failure of at least two prior lines of therapy
June 4, 2021
LUMAKRASTM (Sotorasib) Now Approved
LUMAKRAS (Sotorasib) Now Approved for the Treatment of Adult Patients with KRAS G12C-mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
June 1, 2021
ALUNBRIG® Available From Onco360
ALUNBRIG® (brigatinib) Approved for the Treatment of Adult Patients with Anaplastic Lymphoma Kinase (ALK)-positive Metastatic Non-Small Cell Lung Cancer (NSCLC)
March 15, 2021
Onco360 Selected as Partner for FOTIVDA
Onco360® Selected as Specialty Pharmacy Partner for FOTIVDA® (tivozanib)